Drug Wars

Drug Wars dissects the complex pharmaceutical industry and its practices around drug pricing, patents, and market competition. The book focuses on strategies used by drug companies to maintain monopolies and block access to lower-cost medications. Feldman, a legal scholar and researcher, documents specific cases and tactics employed within the pharmaceutical sector through interviews and analysis of legal records. The narrative tracks major developments in drug pricing and policy from the 1980s through present day. The investigation covers key players across healthcare including drug manufacturers, pharmacy benefit managers, insurance companies, and government regulators. Technical concepts are presented in clear language accessible to general readers. The book raises fundamental questions about how the American healthcare system balances innovation incentives against public access to essential medicines. Through its examination of the pharmaceutical industry, it reveals broader patterns about corporate power and market dysfunction in modern capitalism.

Readers describe the book as a detailed investigation of pharmaceutical pricing and anti-competitive practices, backed by extensive research and data. Readers appreciated: - Clear explanations of complex drug pricing systems - Specific examples and case studies - Policy recommendations and potential solutions - Accessible writing style for non-experts Common criticisms: - Too much focus on legal/regulatory details - Repetitive points in some chapters - Limited coverage of international drug markets - Some readers wanted more emphasis on proposed reforms Ratings: Goodreads: 4.0/5 (28 ratings) Amazon: 4.4/5 (47 ratings) Representative review quotes: "Explains the gaming of patent laws without getting bogged down in jargon" - Amazon reviewer "Good research but could have been shorter" - Goodreads reviewer "Missing perspective from pharma industry insiders" - LibraryThing reviewer

Bad Pharma by Ben Goldacre Documents the pharmaceutical industry's manipulation of clinical trials and data to influence drug approvals and marketing.

Bottle of Lies by Katherine Eban Investigates the rise of generic drug manufacturing in India and the quality control issues that affect global medicine supply.

The Truth About the Drug Companies by Marcia Angell Examines the pharmaceutical industry's pricing strategies, marketing tactics, and influence on medical research.

Empire of Pain by Patrick Radden Keefe Chronicles the Sackler family's role in the opioid crisis through their company Purdue Pharma and the marketing of OxyContin.

White Market Drugs by David Herzberg Traces the history of prescription drug abuse in America and the pharmaceutical industry's role in creating legal drug markets.

🔹 Robin Feldman used her background as both a law professor and bioscience expert to analyze more than 1,800 pharmaceutical patents while writing this book, revealing patterns in how drug companies maintain their monopolies. 🔹 The average price increase for prescription drugs that face no competition is 68% over a five-year period, according to research cited in Drug Wars. 🔹 One strategy exposed in the book is "skinny labeling," where drug companies slightly modify existing medications just enough to earn new patents, effectively extending their market control. 🔹 The author demonstrates how pharmaceutical companies spend more money on marketing existing drugs than on research and development for new medications. 🔹 Drug Wars reveals that for every $1 spent on basic research, pharmaceutical companies spend $19 on promotion and advertising.